Scarica l'app Stockscreener
20.62
2.84%
0.57
Dopo l'orario di chiusura:
20.60
-0.02
-0.10%
Pharvaris Nv Borsa (PHVS) Ultime notizie
What analysts say about Pharvaris N.V. stockRecord-setting profit potential - Autocar Professional
Pharvaris' $201.2M Funding: A Strategic Catalyst for HAE Treatment Innovation and Shareholder Value - AInvest
How Pharvaris N.V. stock reacts to Fed policy changesRapidly growing investment returns - jammulinksnews.com
Pharvaris Raises $201 Million in Successful Offering - TipRanks
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Stock Titan
Is Pharvaris N.V. a good long term investmentRapid growth opportunities - Autocar Professional
Pharvaris: Deucrictibant Advanced To Target Two Sets Of HAE Patient Populations (PHVS) - Seeking Alpha
What drives Pharvaris N.V. stock priceHigh-yield capital appreciation - jammulinksnews.com
Pharvaris shares slide following $175 million equity offering - MSN
Pharvaris stock drops after pricing $175 million public offering By Investing.com - Investing.com Nigeria
Pharvaris' $175M Equity Raise: A Strategic Catalyst for HAE Market Leadership - AInvest
Pharvaris N.V. Stock Analysis and ForecastExponential return rates - jammulinksnews.com
Pharvaris' $175M Equity Raise: Fueling a Strategic Leap in the HAE Market - AInvest
Pharvaris prices $175 million public offering to fund angioedema programs By Investing.com - Investing.com India
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Pharvaris prices $175 million public offering to fund angioedema programs - Investing.com
Pharvaris Secures Massive $175M Public Offering to Advance Oral HAE Treatment Pipeline - Stock Titan
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewswire Inc.
Pharvaris' $150M Share Offering: Balancing Dilution Risk and HAE Market Capture in a High-Margin Niche - AInvest
IKNA issues special CVR dividend ahead of Inmagene merger | PHVS SEC FilingForm 424B5 - Stock Titan
Pharvaris announces $150M ordinary shares offering - TipRanks
Pharvaris Announces Proposed Public Offering of Ordinary Shares - The Manila Times
Pharvaris Seeks $150M in Public Offering: Major Push for Late-Stage HAE Drug Development - Stock Titan
Understanding Stock Volatility in the Indian Market AI Driven Stock AlertsFree Risk Assessment Services - Autocar Professional
Property Share Investment Trust (544295) Hits 52 Week HighRapid wealth creation - Autocar Professional
What drives PTON stock priceBreakout stock performance - jammulinksnews.com
What drives iShares Gold Trust stock priceHigh-yield capital appreciation - jammulinksnews.com
NSE Quality Stocks Smart Investor Club PicksHigh-velocity gains - jammulinksnews.com
Best Renewable Stocks Smart Money Stock PicksPowerful growth strategies - jammulinksnews.com
What risks could impact Pharvaris N.V. stock performanceHigh Return Stock Alerts - Newser
Pharvaris: More Convenience, More Potency, And More Potential For Future HAE Success - Seeking Alpha
How To Trade (PHVS) - news.stocktradersdaily.com
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):